For many years, the only specific pharmacologic intervention to decrease end-stage kidney disease in diabetic kidney disease was renin-angiotensin-aldosterone system blockade. Despite the addition …

IgA nephropathy (IgAN) is the most common immune-mediated glomerular disease worldwide. Advanced understanding of the role of complement in IgAN pathogenesis has motivated the development of comple…

IgA nephropathy (IgAN) is the most common immune-mediated glomerular disease worldwide. Advanced understanding of the role of complement in IgAN pathogenesis has motivated the development of comple…

Podcast Episode · Freely Filtered, a NephJC Podcast · 11/28/2025 · 1h 15m

AJKDBlog Interviews Editor Timothy Yau (@Maximal_Change) talked with Alexander Chang (@alexchangmd) and Evan Zeitler (@LittleBigGloms) about their recently published AJKD Perspective, which recomme…

The increasing availability of clinically approved genetic tests for kidney disease has spurred the growth in the use of these tests in kidney transpl…

Developing strategies to improve home dialysis use requires a comprehensive understanding of barriers. In a study recently published in AJKD,  Yuvaram N.V. Reddy and colleagues sought to identify t…

This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythm...